SIMILAR PATTERNS OF AMINO ACIDS FOR 4AN2_A_EUIA1382

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nd4 AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E

(Klebsiella
pneumoniae) 		PF01636
(APH) 		6 LEU A  60
LEU A  92
ASP A 190
ASN A 195
ASP A 208
GLY A 210
 None
None
KAN  A1300 ( 2.8A)
MG  A 400 (-2.7A)
MG  A 400 (-3.2A)
None
 1.29A 4an2A-1nd4A:
7.0		 4an2A-1nd4A:
21.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		11 LYS A 101
LEU A 119
LEU A 122
ILE A 145
MET A 147
ASP A 194
LYS A 196
ASN A 199
ASP A 212
GLY A 214
VAL A 215
 ATP  A 535 ( 2.5A)
5EA  A1001 (-4.9A)
5EA  A1001 (-4.9A)
5EA  A1001 ( 3.7A)
ATP  A 535 ( 3.4A)
ATP  A 535 ( 3.4A)
ATP  A 535 (-2.7A)
MG  A 536 (-2.8A)
MG  A 536 (-3.3A)
5EA  A1001 (-3.6A)
5EA  A1001 (-3.9A)
 0.47A 4an2A-1s9iA:
39.5		 4an2A-1s9iA:
74.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bgs ALDOSE REDUCTASE

(Hordeum vulgare) 		PF00248
(Aldo_ket_red) 		6 LEU A 173
LEU A 176
ASP A 162
GLY A 164
VAL A 165
GLY A  21
 None
 1.45A 4an2A-2bgsA:
undetectable		 4an2A-2bgsA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		6 LYS A 295
LEU A 325
ILE A 336
ASP A 386
ASN A 391
GLY A 406
 H8H  A 534 (-3.7A)
None
H8H  A 534 ( 4.5A)
None
H8H  A 534 ( 4.9A)
None
 1.04A 4an2A-2h8hA:
26.0		 4an2A-2h8hA:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hck HEMATOPOETIC CELL
KINASE HCK

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		7 LYS A 295
LEU A 325
ILE A 336
ASP A 386
ASN A 391
ASP A 404
GLY A 406
 None
 1.02A 4an2A-2hckA:
26.3		 4an2A-2hckA:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iu4 DIHYDROXYACETONE
KINASE

(Lactococcus
lactis) 		PF02733
(Dak1) 		6 LEU A  25
LEU A  34
ILE A  18
MET A  14
VAL A  62
GLY A 292
 None
 1.39A 4an2A-2iu4A:
undetectable		 4an2A-2iu4A:
26.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ji9 OXALYL-COA
DECARBOXYLASE

(Oxalobacter
formigenes) 		PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N) 		5 LEU A 529
LEU A 525
ILE A 475
GLY A 382
VAL A 383
 None
 0.75A 4an2A-2ji9A:
undetectable		 4an2A-2ji9A:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pzi PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNG

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase)
PF16918
(PknG_TPR)
PF16919
(PknG_rubred) 		7 LYS A 181
ILE A 230
MET A 232
ASP A 276
LYS A 278
ASN A 281
ASP A 293
 AXX  A 753 ( 4.3A)
None
AXX  A 753 (-3.6A)
None
None
None
AXX  A 753 ( 4.4A)
 0.92A 4an2A-2pziA:
8.8		 4an2A-2pziA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pzi PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNG

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase)
PF16918
(PknG_TPR)
PF16919
(PknG_rubred) 		7 LYS A 181
LEU A 202
ILE A 230
MET A 232
LYS A 278
ASN A 281
ASP A 293
 AXX  A 753 ( 4.3A)
None
None
AXX  A 753 (-3.6A)
None
None
AXX  A 753 ( 4.4A)
 1.03A 4an2A-2pziA:
8.8		 4an2A-2pziA:
19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qlu ACTIVIN RECEPTOR
TYPE IIB

(Homo sapiens) 		PF00069
(Pkinase) 		5 LYS A 217
ASP A 321
LYS A 323
ASN A 326
ASP A 339
 None
None
SO4  A   2 (-3.0A)
None
None
 0.76A 4an2A-2qluA:
22.4		 4an2A-2qluA:
28.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w9f CELL DIVISION
PROTEIN KINASE 4

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS B  35
ASP B 140
LYS B 142
ASN B 145
ASP B 158
GLY B 160
 None
 1.17A 4an2A-2w9fB:
23.6		 4an2A-2w9fB:
29.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w9f CELL DIVISION
PROTEIN KINASE 4

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS B  35
LEU B  60
ASP B 140
LYS B 142
ASN B 145
ASP B 158
 None
 1.29A 4an2A-2w9fB:
23.6		 4an2A-2w9fB:
29.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wbm RIBOSOME MATURATION
PROTEIN SDO1 HOMOLOG

(Methanothermobacter
thermautotrophicus) 		PF01172
(SBDS)
PF09377
(SBDS_C) 		5 LEU A 218
LEU A 221
ILE A 171
GLY A 181
VAL A 182
 None
 0.76A 4an2A-2wbmA:
undetectable		 4an2A-2wbmA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y7j PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  81
ASP A 153
LYS A 155
ASN A 158
ASP A 171
 None
None
None
None
B49  A1294 (-4.2A)
 0.67A 4an2A-2y7jA:
25.1		 4an2A-2y7jA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3coi MITOGEN-ACTIVATED
PROTEIN KINASE 13

(Homo sapiens) 		PF00069
(Pkinase) 		5 ASP A 150
LYS A 152
ASN A 155
ASP A 168
GLY A 170
 None
 0.73A 4an2A-3coiA:
20.5		 4an2A-3coiA:
27.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dtc MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 9

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 MET A 220
ASP A 268
LYS A 270
ASN A 273
GLY A 296
GLY A 311
 VIN  A6331 (-3.7A)
SO4  A8001 ( 4.8A)
SO4  A8001 (-3.0A)
VIN  A6331 ( 4.8A)
None
None
 0.97A 4an2A-3dtcA:
25.9		 4an2A-3dtcA:
28.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dxn CALMODULIN-LIKE
DOMAIN PROTEIN
KINASE ISOFORM 3

(Toxoplasma
gondii) 		PF00069
(Pkinase) 		6 LEU A  75
MET A 100
ASP A 146
LYS A 148
ASN A 151
ASP A 167
 None
 0.78A 4an2A-3dxnA:
27.1		 4an2A-3dxnA:
28.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dxn CALMODULIN-LIKE
DOMAIN PROTEIN
KINASE ISOFORM 3

(Toxoplasma
gondii) 		PF00069
(Pkinase) 		6 LEU A  86
ASP A 146
LYS A 148
ASN A 151
ASP A 167
GLY A 169
 None
 0.95A 4an2A-3dxnA:
27.1		 4an2A-3dxnA:
28.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dxn CALMODULIN-LIKE
DOMAIN PROTEIN
KINASE ISOFORM 3

(Toxoplasma
gondii) 		PF00069
(Pkinase) 		6 MET A 100
ASP A 146
LYS A 148
ASN A 151
ASP A 167
GLY A 169
 None
 0.68A 4an2A-3dxnA:
27.1		 4an2A-3dxnA:
28.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eat PYOVERDINE
BIOSYNTHESIS PROTEIN
PVCB

(Pseudomonas
aeruginosa) 		PF02668
(TauD) 		6 LEU X  58
LEU X 249
ILE X 251
ASP X  76
GLY X  39
VAL X  38
 None
 1.18A 4an2A-3eatX:
undetectable		 4an2A-3eatX:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eo3 BIFUNCTIONAL
UDP-N-ACETYLGLUCOSAM
INE
2-EPIMERASE/N-ACETYL
MANNOSAMINE KINASE

(Homo sapiens) 		PF00480
(ROK) 		6 LEU A 504
ILE A 449
ASP A 515
GLY A 471
VAL A 470
GLY A 518
 None
 1.24A 4an2A-3eo3A:
undetectable		 4an2A-3eo3A:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gbz KINASE, CMGC CDK

(Giardia
intestinalis) 		PF00069
(Pkinase) 		6 LYS A  44
ASP A 136
LYS A 138
ASN A 141
ASP A 159
GLY A 161
 None
 1.25A 4an2A-3gbzA:
24.5		 4an2A-3gbzA:
25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gbz KINASE, CMGC CDK

(Giardia
intestinalis) 		PF00069
(Pkinase) 		6 LYS A  44
LEU A  66
ASP A 136
LYS A 138
ASN A 141
ASP A 159
 None
 1.36A 4an2A-3gbzA:
24.5		 4an2A-3gbzA:
25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3

(Toxoplasma
gondii) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		6 LYS A 105
LEU A 128
MET A 153
ASP A 199
ASN A 204
ASP A 220
 GOL  A   1 (-2.7A)
None
GOL  A   1 ( 3.0A)
None
GOL  A 542 ( 4.8A)
J60  A 540 ( 3.6A)
 1.47A 4an2A-3hztA:
22.0		 4an2A-3hztA:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3

(Toxoplasma
gondii) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		7 LYS A 105
LEU A 128
MET A 153
ASP A 199
LYS A 201
ASN A 204
ASP A 220
 GOL  A   1 (-2.7A)
None
GOL  A   1 ( 3.0A)
None
None
GOL  A 542 ( 4.8A)
J60  A 540 ( 3.6A)
 1.26A 4an2A-3hztA:
22.0		 4an2A-3hztA:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3is5 CALCIUM-DEPENDENT
PROTEIN KINASE

(Toxoplasma
gondii) 		PF00069
(Pkinase) 		6 LYS A 164
ILE A 208
MET A 210
ASP A 260
ASN A 265
ASP A 281
 GOL  A 398 ( 3.1A)
None
GOL  A 398 ( 3.6A)
None
MG  A 399 (-3.0A)
MG  A 399 ( 3.0A)
 0.93A 4an2A-3is5A:
19.1		 4an2A-3is5A:
27.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm5 SERINE/THREONINE-PRO
TEIN KINASE 17B

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  84
ASP A 158
LYS A 160
ASN A 163
ASP A 179
GLY A 197
 QUE  A   1 ( 4.6A)
None
None
None
QUE  A   1 (-2.9A)
None
 1.09A 4an2A-3lm5A:
24.1		 4an2A-3lm5A:
26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm5 SERINE/THREONINE-PRO
TEIN KINASE 17B

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A 108
LEU A  84
ASP A 158
LYS A 160
ASN A 163
ASP A 179
 None
QUE  A   1 ( 4.6A)
None
None
None
QUE  A   1 (-2.9A)
 1.47A 4an2A-3lm5A:
24.1		 4an2A-3lm5A:
26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm5 SERINE/THREONINE-PRO
TEIN KINASE 17B

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A 108
LEU A  84
LYS A 160
ASN A 163
ASP A 179
GLY A 181
 None
QUE  A   1 ( 4.6A)
None
None
QUE  A   1 (-2.9A)
None
 1.42A 4an2A-3lm5A:
24.1		 4an2A-3lm5A:
26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm5 SERINE/THREONINE-PRO
TEIN KINASE 17B

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A 108
LEU A 110
ASP A 158
LYS A 160
ASN A 163
ASP A 179
 None
QUE  A   1 (-4.1A)
None
None
None
QUE  A   1 (-2.9A)
 1.45A 4an2A-3lm5A:
24.1		 4an2A-3lm5A:
26.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o0d TRIACYLGLYCEROL
LIPASE

(Yarrowia
lipolytica) 		PF01764
(Lipase_3)
PF03893
(Lipase3_N) 		6 LEU A 170
LEU A 169
ILE A 173
ASN A 199
GLY A 193
VAL A 192
 None
None
None
None
None
K  A 308 ( 4.6A)
 1.19A 4an2A-3o0dA:
undetectable		 4an2A-3o0dA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rc0 N-LYSINE
METHYLTRANSFERASE
SETD6

(Homo sapiens) 		PF00856
(SET)
PF09273
(Rubis-subs-bind) 		6 LEU A 468
LEU A 465
ILE A 356
ASP A 312
VAL A 420
GLY A 349
 None
 1.33A 4an2A-3rc0A:
undetectable		 4an2A-3rc0A:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rw9 SPERMIDINE SYNTHASE

(Homo sapiens) 		PF01564
(Spermine_synth)
PF17284
(Spermine_synt_N) 		6 LEU A 151
ILE A 130
ASP A 126
GLY A 154
VAL A 153
GLY A 179
 None
 1.45A 4an2A-3rw9A:
undetectable		 4an2A-3rw9A:
23.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 LYS A  73
ILE A 116
MET A 118
ASP A 166
ASN A 171
 I85  A 350 (-2.8A)
None
I85  A 350 ( 3.9A)
None
I85  A 350 (-4.4A)
 0.75A 4an2A-3sheA:
18.3		 4an2A-3sheA:
25.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vn9 DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		7 LYS A  82
ILE A 127
MET A 129
ASP A 179
LYS A 181
ASN A 184
ASP A 197
 ANK  A 401 (-2.4A)
None
ANK  A 401 (-3.7A)
ANK  A 401 (-3.7A)
ANK  A 401 (-2.5A)
ANK  A 401 ( 2.7A)
MG  A 402 ( 2.8A)
 0.75A 4an2A-3vn9A:
33.7		 4an2A-3vn9A:
39.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vn9 DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		7 LYS A  82
MET A 129
ASP A 179
LYS A 181
ASN A 184
ASP A 197
GLY A 199
 ANK  A 401 (-2.4A)
ANK  A 401 (-3.7A)
ANK  A 401 (-3.7A)
ANK  A 401 (-2.5A)
ANK  A 401 ( 2.7A)
MG  A 402 ( 2.8A)
None
 0.80A 4an2A-3vn9A:
33.7		 4an2A-3vn9A:
39.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wig DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		8 LYS A  98
LEU A 116
ILE A 142
ASP A 191
LYS A 193
ASN A 196
ASP A 209
GLY A 211
 ANP  A 401 (-2.7A)
None
CHU  A 403 (-3.8A)
CHU  A 403 (-3.6A)
ANP  A 401 (-3.0A)
MG  A 402 ( 2.9A)
MG  A 402 (-3.2A)
CHU  A 403 ( 3.3A)
 1.50A 4an2A-3wigA:
40.7		 4an2A-3wigA:
94.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wig DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		11 LYS A  98
LEU A 116
LEU A 119
ILE A 142
MET A 144
ASP A 191
LYS A 193
ASN A 196
ASP A 209
GLY A 211
VAL A 212
 ANP  A 401 (-2.7A)
None
CHU  A 403 (-4.4A)
CHU  A 403 (-3.8A)
CHU  A 403 (-3.8A)
CHU  A 403 (-3.6A)
ANP  A 401 (-3.0A)
MG  A 402 ( 2.9A)
MG  A 402 (-3.2A)
CHU  A 403 ( 3.3A)
CHU  A 403 ( 4.0A)
 0.48A 4an2A-3wigA:
40.7		 4an2A-3wigA:
94.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4agu CYCLIN-DEPENDENT
KINASE-LIKE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  78
LEU A  55
ASP A 126
LYS A 128
ASN A 131
GLY A 146
 None
None
None
D15  A 500 ( 4.8A)
D15  A 500 (-3.0A)
None
 1.48A 4an2A-4aguA:
24.1		 4an2A-4aguA:
28.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw2 SERINE/THREONINE-PRO
TEIN KINASE MRCK
ALPHA

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		6 LEU A 108
LEU A 152
ASP A 201
LYS A 203
ASN A 206
GLY A 221
 EDO  A1419 (-4.2A)
None
None
None
None
EDO  A1419 (-3.7A)
 1.24A 4an2A-4aw2A:
22.3		 4an2A-4aw2A:
24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw2 SERINE/THREONINE-PRO
TEIN KINASE MRCK
ALPHA

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		6 LEU A 152
LEU A 129
ASP A 201
LYS A 203
ASN A 206
GLY A 221
 None
None
None
None
None
EDO  A1419 (-3.7A)
 1.37A 4an2A-4aw2A:
22.3		 4an2A-4aw2A:
24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c02 ACTIVIN RECEPTOR
TYPE-1

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		6 LEU A 281
ASP A 336
LYS A 338
ASN A 341
ASP A 354
GLY A 356
 None
None
FLC  A1504 (-2.8A)
None
TAK  A1507 (-3.5A)
None
 1.33A 4an2A-4c02A:
22.5		 4an2A-4c02A:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c02 ACTIVIN RECEPTOR
TYPE-1

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		5 LYS A 235
ASP A 336
LYS A 338
ASN A 341
ASP A 354
 TAK  A1507 ( 4.5A)
None
FLC  A1504 (-2.8A)
None
TAK  A1507 (-3.5A)
 0.65A 4an2A-4c02A:
22.5		 4an2A-4c02A:
26.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ejy 3-METHYLADENINE DNA
GLYCOSYLASE

(Caldanaerobacter
subterraneus) 		PF00730
(HhH-GPD)
PF07934
(OGG_N) 		6 LEU A 212
LEU A 118
ILE A 195
ASP A 185
GLY A 217
VAL A 218
 None
None
None
None
NA  A 301 ( 4.9A)
NA  A 301 (-4.6A)
 1.47A 4an2A-4ejyA:
undetectable		 4an2A-4ejyA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eqm PROTEIN KINASE

(Staphylococcus
aureus) 		PF00069
(Pkinase) 		6 LYS A  39
MET A  87
ASP A 133
LYS A 135
ASN A 138
ASP A 151
 ANP  A 300 (-3.1A)
ANP  A 300 (-3.6A)
None
None
None
None
 0.88A 4an2A-4eqmA:
25.3		 4an2A-4eqmA:
26.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fg8 CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A  49
LEU A  70
MET A  95
ASP A 141
LYS A 143
ASN A 146
 ATP  A 401 (-3.0A)
None
ATP  A 401 ( 4.3A)
ATP  A 401 ( 4.6A)
None
ATP  A 401 (-3.4A)
 1.05A 4an2A-4fg8A:
24.1		 4an2A-4fg8A:
26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fl3 TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 LYS A 402
MET A 448
ASN A 499
ASP A 512
GLY A 514
 ANP  A 701 (-2.7A)
ANP  A 701 ( 3.7A)
MG  A 702 ( 3.0A)
MG  A 702 ( 3.1A)
None
 0.56A 4an2A-4fl3A:
25.8		 4an2A-4fl3A:
17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		6 LEU A 443
LEU A 457
ILE A 469
ASN A 522
ASP A 536
GLY A 560
 None
None
0WB  A 701 (-3.9A)
0WB  A 701 (-4.1A)
0WB  A 701 (-3.1A)
None
 1.08A 4an2A-4g3fA:
25.7		 4an2A-4g3fA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		6 LEU A 457
ILE A 469
ASP A 517
LYS A 519
ASN A 522
ASP A 536
 None
0WB  A 701 (-3.9A)
None
None
0WB  A 701 (-4.1A)
0WB  A 701 (-3.1A)
 1.16A 4an2A-4g3fA:
25.7		 4an2A-4g3fA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		6 LYS A 431
ILE A 469
ASP A 517
LYS A 519
ASN A 522
ASP A 536
 0WB  A 701 (-3.0A)
0WB  A 701 (-3.9A)
None
None
0WB  A 701 (-4.1A)
0WB  A 701 (-3.1A)
 1.05A 4an2A-4g3fA:
25.7		 4an2A-4g3fA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		6 LYS A 431
LEU A 443
ILE A 469
ASN A 522
ASP A 536
GLY A 560
 0WB  A 701 (-3.0A)
None
0WB  A 701 (-3.9A)
0WB  A 701 (-4.1A)
0WB  A 701 (-3.1A)
None
 1.24A 4an2A-4g3fA:
25.7		 4an2A-4g3fA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		6 LYS A 431
MET A 471
ASP A 517
LYS A 519
ASN A 522
ASP A 536
 0WB  A 701 (-3.0A)
0WB  A 701 (-3.9A)
None
None
0WB  A 701 (-4.1A)
0WB  A 701 (-3.1A)
 1.16A 4an2A-4g3fA:
25.7		 4an2A-4g3fA:
27.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gv1 RAC-ALPHA
SERINE/THREONINE-PRO
TEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		6 MET A 227
ASP A 274
LYS A 276
ASN A 279
ASP A 292
VAL A 201
 0XZ  A 501 (-3.8A)
None
0XZ  A 501 ( 4.4A)
0XZ  A 501 ( 4.5A)
0XZ  A 501 ( 3.4A)
None
 1.19A 4an2A-4gv1A:
25.3		 4an2A-4gv1A:
25.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hyv PYRUVATE KINASE 1

(Trypanosoma
brucei) 		PF00224
(PK)
PF02887
(PK_C) 		6 LEU A 198
ILE A 209
ASN A  52
ASP A  84
GLY A  87
GLY A 264
 None
None
K  A1002 (-3.3A)
K  A1002 (-3.4A)
None
PEP  A1003 (-3.3A)
 1.35A 4an2A-4hyvA:
undetectable		 4an2A-4hyvA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		5 ILE A 467
MET A 469
ASP A 515
LYS A 517
ASN A 520
 None
T28  A 701 (-2.6A)
None
None
T28  A 701 ( 4.9A)
 0.63A 4an2A-4idtA:
25.4		 4an2A-4idtA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A 429
LEU A 441
ILE A 467
ASN A 520
ASP A 534
GLY A 558
 T28  A 701 ( 3.8A)
None
None
T28  A 701 ( 4.9A)
T28  A 701 ( 3.4A)
None
 1.46A 4an2A-4idtA:
25.4		 4an2A-4idtA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A 429
LEU A 441
ILE A 467
ASP A 515
ASN A 520
ASP A 534
 T28  A 701 ( 3.8A)
None
None
None
T28  A 701 ( 4.9A)
T28  A 701 ( 3.4A)
 1.15A 4an2A-4idtA:
25.4		 4an2A-4idtA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A 429
LEU A 441
ILE A 467
MET A 469
ASN A 520
GLY A 558
 T28  A 701 ( 3.8A)
None
None
T28  A 701 (-2.6A)
T28  A 701 ( 4.9A)
None
 1.31A 4an2A-4idtA:
25.4		 4an2A-4idtA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A 429
LEU A 441
ILE A 467
MET A 469
ASP A 515
ASN A 520
 T28  A 701 ( 3.8A)
None
None
T28  A 701 (-2.6A)
None
T28  A 701 ( 4.9A)
 0.94A 4an2A-4idtA:
25.4		 4an2A-4idtA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A 429
LEU A 441
LEU A 455
ILE A 467
ASP A 515
ASP A 534
 T28  A 701 ( 3.8A)
None
None
None
None
T28  A 701 ( 3.4A)
 1.40A 4an2A-4idtA:
25.4		 4an2A-4idtA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k11 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		6 LYS A 295
ILE A 336
ASP A 386
ASN A 391
ASP A 404
GLY A 406
 0J9  A 601 ( 4.7A)
0J9  A 601 (-4.4A)
None
None
0J9  A 601 (-3.1A)
None
 0.57A 4an2A-4k11A:
25.9		 4an2A-4k11A:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lrj EFFECTOR NLEH1

(Escherichia
coli) 		no annotation 6 LYS A 159
ILE A 199
MET A 201
ASP A 239
ASN A 244
ASP A 258
 ANP  A 301 (-3.6A)
None
ANP  A 301 (-3.5A)
None
MG  A 302 ( 4.4A)
MG  A 302 ( 2.9A)
 0.92A 4an2A-4lrjA:
8.4		 4an2A-4lrjA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m69 RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 3

(Mus musculus) 		PF00069
(Pkinase) 		6 LYS A  51
ASP A 143
LYS A 145
ASN A 148
ASP A 161
GLY A 163
 ANP  A 401 (-2.9A)
ANP  A 401 (-2.6A)
ANP  A 401 (-3.0A)
MG  A 403 ( 2.6A)
MG  A 403 ( 3.1A)
None
 0.72A 4an2A-4m69A:
25.9		 4an2A-4m69A:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m69 RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 3

(Mus musculus) 		PF00069
(Pkinase) 		6 LYS A  51
LEU A  76
ASP A 143
LYS A 145
ASN A 148
ASP A 161
 ANP  A 401 (-2.9A)
None
ANP  A 401 (-2.6A)
ANP  A 401 (-3.0A)
MG  A 403 ( 2.6A)
MG  A 403 ( 3.1A)
 1.04A 4an2A-4m69A:
25.9		 4an2A-4m69A:
27.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ow8 SERINE/THREONINE-PRO
TEIN KINASE PKNA

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase) 		8 LYS A  42
MET A  95
ASP A 141
LYS A 143
ASN A 146
ASP A 159
GLY A 161
GLY A 179
 None
 1.05A 4an2A-4ow8A:
25.0		 4an2A-4ow8A:
27.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4psw HISTONE
ACETYLTRANSFERASE
TYPE B CATALYTIC
SUBUNIT

(Saccharomyces
cerevisiae) 		PF00583
(Acetyltransf_1)
PF10394
(Hat1_N) 		5 LEU A  91
LEU A  87
ILE A 155
VAL A  67
GLY A  25
 None
 0.71A 4an2A-4pswA:
undetectable		 4an2A-4pswA:
22.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q9z HUMAN PROTEIN KINASE
C THETA

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 LEU A 432
ASP A 504
LYS A 506
ASN A 509
ASP A 522
 None
None
None
PZW  A 801 (-4.4A)
PZW  A 801 (-3.2A)
 0.74A 4an2A-4q9zA:
23.6		 4an2A-4q9zA:
27.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rgj CALCIUM-DEPENDENT
PROTEIN KINASE 4

(Plasmodium
falciparum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 LYS A  99
LYS A 195
ASN A 198
ASP A 215
GLY A 217
 None
 0.74A 4an2A-4rgjA:
23.6		 4an2A-4rgjA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uy9 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 9

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A 218
ASP A 268
LYS A 270
ASN A 273
ASP A 294
GLY A 296
 None
 1.21A 4an2A-4uy9A:
25.8		 4an2A-4uy9A:
27.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wb7 DNAJ HOMOLOG
SUBFAMILY B MEMBER
1,CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase)
PF00226
(DnaJ) 		5 LYS A 127
MET A 175
ASP A 221
LYS A 223
ASN A 226
 ATP  A 501 (-2.6A)
ATP  A 501 (-3.6A)
ATP  A 501 (-4.2A)
ATP  A 501 (-2.7A)
ZN  A 502 ( 2.5A)
 0.67A 4an2A-4wb7A:
24.8		 4an2A-4wb7A:
24.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wsq AP2-ASSOCIATED
PROTEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ILE A 124
MET A 126
ASP A 176
LYS A 178
ASN A 181
 None
KSA  A 405 ( 3.7A)
ZN  A 403 (-3.2A)
ZN  A 403 ( 4.3A)
KSA  A 405 (-4.0A)
 0.70A 4an2A-4wsqA:
23.2		 4an2A-4wsqA:
26.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x3f SERINE/THREONINE-PRO
TEIN KINASE PKNA

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase) 		6 LEU A  44
LEU A  93
ASN A 146
ASP A 159
GLY A 161
GLY A 179
 None
 1.42A 4an2A-4x3fA:
24.5		 4an2A-4x3fA:
27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0x SERINE/THREONINE-PRO
TEIN KINASE PKNG

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase)
PF16919
(PknG_rubred) 		6 ILE A 230
MET A 232
ASP A 276
LYS A 278
ASN A 281
GLY A 308
 None
ADP  A 501 (-3.3A)
None
MG  A 503 ( 4.8A)
MG  A 503 ( 2.9A)
None
 1.20A 4an2A-4y0xA:
15.3		 4an2A-4y0xA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0x SERINE/THREONINE-PRO
TEIN KINASE PKNG

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase)
PF16919
(PknG_rubred) 		6 LYS A 181
ILE A 230
MET A 232
ASP A 276
LYS A 278
ASN A 281
 ADP  A 501 (-2.7A)
None
ADP  A 501 (-3.3A)
None
MG  A 503 ( 4.8A)
MG  A 503 ( 2.9A)
 0.86A 4an2A-4y0xA:
15.3		 4an2A-4y0xA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0x SERINE/THREONINE-PRO
TEIN KINASE PKNG

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase)
PF16919
(PknG_rubred) 		6 LYS A 181
LEU A 202
ILE A 230
LYS A 278
ASN A 281
ASP A 293
 ADP  A 501 (-2.7A)
None
None
MG  A 503 ( 4.8A)
MG  A 503 ( 2.9A)
MG  A 504 (-2.3A)
 1.18A 4an2A-4y0xA:
15.3		 4an2A-4y0xA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0x SERINE/THREONINE-PRO
TEIN KINASE PKNG

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase)
PF16919
(PknG_rubred) 		6 LYS A 181
LEU A 202
ILE A 230
MET A 232
LYS A 278
ASN A 281
 ADP  A 501 (-2.7A)
None
None
ADP  A 501 (-3.3A)
MG  A 503 ( 4.8A)
MG  A 503 ( 2.9A)
 0.98A 4an2A-4y0xA:
15.3		 4an2A-4y0xA:
22.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4yc6 CYCLIN-DEPENDENT
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  66
ASP A 128
LYS A 130
ASN A 133
ASP A 146
GLY A 148
 None
 1.17A 4an2A-4yc6A:
25.0		 4an2A-4yc6A:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4yc6 CYCLIN-DEPENDENT
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A  33
ASP A 128
LYS A 130
ASN A 133
ASP A 146
GLY A 148
 None
 0.98A 4an2A-4yc6A:
25.0		 4an2A-4yc6A:
30.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4yc6 CYCLIN-DEPENDENT
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A  33
LEU A  55
ASP A 128
LYS A 130
ASN A 133
ASP A 146
 None
 1.09A 4an2A-4yc6A:
25.0		 4an2A-4yc6A:
30.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z7g SERINE/THREONINE-PRO
TEIN
KINASE/ENDORIBONUCLE
ASE IRE1

(Homo sapiens) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A) 		6 LEU A 616
ILE A 640
ASP A 688
LYS A 690
ASN A 693
ASP A 711
 None
 1.03A 4an2A-4z7gA:
19.1		 4an2A-4z7gA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z7g SERINE/THREONINE-PRO
TEIN
KINASE/ENDORIBONUCLE
ASE IRE1

(Homo sapiens) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A) 		6 LEU A 616
ILE A 642
ASP A 688
LYS A 690
ASN A 693
ASP A 711
 None
 1.44A 4an2A-4z7gA:
19.1		 4an2A-4z7gA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hes MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LYS A  45
LEU A  57
ASP A 133
LYS A 135
ASN A 138
ASP A 151
 032  A 401 (-4.4A)
032  A 401 ( 4.7A)
None
None
None
032  A 401 (-4.6A)
 0.97A 4an2A-5hesA:
24.8		 4an2A-5hesA:
24.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hes MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LYS A  45
LEU A  57
ASP A 133
LYS A 135
ASN A 138
ASP A 151
 032  A 401 (-4.4A)
032  A 401 ( 4.7A)
None
None
None
032  A 401 (-4.6A)
 1.34A 4an2A-5hesA:
24.8		 4an2A-5hesA:
24.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hes MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LYS A  45
LEU A  57
ILE A  80
ASP A 133
LYS A 135
ASN A 138
 032  A 401 (-4.4A)
032  A 401 ( 4.7A)
032  A 401 (-4.0A)
None
None
None
 0.89A 4an2A-5hesA:
24.8		 4an2A-5hesA:
24.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hes MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE MLT

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LYS A  45
LEU A  57
ILE A  80
ASP A 133
LYS A 135
ASN A 138
 032  A 401 (-4.4A)
032  A 401 ( 4.7A)
032  A 401 (-4.0A)
None
None
None
 1.35A 4an2A-5hesA:
24.8		 4an2A-5hesA:
24.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i3o BMP-2-INDUCIBLE
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A  79
ILE A 128
ASP A 180
LYS A 182
ASN A 185
ASP A 198
 IDV  A 401 ( 4.8A)
None
None
IDV  A 401 ( 4.2A)
IDV  A 401 (-4.1A)
IDV  A 401 (-4.0A)
 1.03A 4an2A-5i3oA:
23.2		 4an2A-5i3oA:
27.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i3o BMP-2-INDUCIBLE
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 LYS A  79
ILE A 128
MET A 130
ASP A 180
LYS A 182
ASN A 185
 IDV  A 401 ( 4.8A)
None
IDV  A 401 (-3.4A)
None
IDV  A 401 ( 4.2A)
IDV  A 401 (-4.1A)
 0.79A 4an2A-5i3oA:
23.2		 4an2A-5i3oA:
27.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j0a LYMPHOKINE-ACTIVATED
KILLER
T-CELL-ORIGINATED
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A  89
LEU A  92
ASP A 167
LYS A 169
ASN A 172
ASP A 186
 None
 1.27A 4an2A-5j0aA:
4.3		 4an2A-5j0aA:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k0y EUKARYOTIC
INITIATION FACTOR 2
GAMMA SUBUNIT
(EIF2-GAMMA)

(Oryctolagus
cuniculus) 		PF00009
(GTP_EFTU)
PF03144
(GTP_EFTU_D2)
PF09173
(eIF2_C) 		6 LEU S 269
ILE S 296
ASN S  98
GLY S 351
VAL S 352
GLY S  95
 None
None
None
A  N  75 ( 3.8A)
None
None
 1.38A 4an2A-5k0yS:
undetectable		 4an2A-5k0yS:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m09 SERINE/THREONINE-PRO
TEIN KINASE PKNI

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase) 		6 ILE A  87
MET A  89
ASP A 137
ASN A 142
ASP A 159
GLY A 161
 None
 0.80A 4an2A-5m09A:
21.9		 4an2A-5m09A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m09 SERINE/THREONINE-PRO
TEIN KINASE PKNI

(Mycobacterium
tuberculosis) 		PF00069
(Pkinase) 		6 LYS A  41
ILE A  87
MET A  89
ASN A 142
ASP A 159
GLY A 161
 None
 0.90A 4an2A-5m09A:
21.9		 4an2A-5m09A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mux 2-METHYLCITRATE
DEHYDRATASE

(Bacillus
subtilis) 		no annotation 6 LEU A 261
LEU A 265
ILE A  11
ASN A 108
GLY A 148
VAL A 149
 None
 0.90A 4an2A-5muxA:
undetectable		 4an2A-5muxA:
13.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5myv SRSF PROTEIN KINASE
2,SRSF PROTEIN
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		6 LEU A 140
ASP A 225
LYS A 227
ASN A 230
ASP A 541
GLY A 543
 None
None
None
None
DMS  A 717 (-4.3A)
None
 1.39A 4an2A-5myvA:
20.2		 4an2A-5myvA:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nd1 CAPSID PROTEIN

(Rosellinia
necatrix
quadrivirus 1) 		no annotation 6 LEU B 894
ILE B 893
ASN B 885
GLY B 814
VAL B 815
GLY A 920
 None
 1.21A 4an2A-5nd1B:
undetectable		 4an2A-5nd1B:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wno RECEPTOR
TYROSINE-PROTEIN
KINASE LET-23

(Caenorhabditis
elegans) 		no annotation 6 LYS A 919
ILE A 961
ASP A1010
ASN A1015
ASP A1028
GLY A1030
 ANP  A1201 (-3.8A)
None
ANP  A1201 (-3.7A)
MG  A1202 ( 2.9A)
MG  A1202 ( 3.0A)
None
 0.79A 4an2A-5wnoA:
25.4		 4an2A-5wnoA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xv7 SERINE-ARGININE (SR)
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 5 LEU A 128
ASP A 213
LYS A 215
ASN A 218
ASP A 497
 None
EDO  A 702 ( 4.9A)
None
None
EMH  A 705 (-4.7A)
 0.73A 4an2A-5xv7A:
21.4		 4an2A-5xv7A:
14.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xzw SERINE/THREONINE-PRO
TEIN KINASE RAD53

(Saccharomyces
cerevisiae) 		no annotation 5 LEU A 248
ASP A 319
LYS A 321
ASN A 324
ASP A 339
 None
 0.70A 4an2A-5xzwA:
19.4		 4an2A-5xzwA:
23.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6ao5 SERINE/THREONINE-PRO
TEIN KINASE 3

(Homo sapiens) 		no annotation 6 LYS A  56
ILE A  97
MET A  99
LYS A 148
ASN A 151
ASP A 164
 ANP  A 501 (-2.4A)
None
ANP  A 501 (-2.5A)
ANP  A 501 (-3.1A)
ANP  A 501 ( 2.6A)
MG  A 502 ( 3.1A)
 0.60A 4an2A-6ao5A:
29.2		 4an2A-6ao5A:
33.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eqi SERINE/THREONINE-PRO
TEIN KINASE PINK1,
PUTATIVE

(Pediculus
humanus) 		no annotation 6 LYS C 193
MET C 290
ASP C 334
ASN C 339
ASP C 357
VAL C 216
 None
 1.21A 4an2A-6eqiC:
19.8		 4an2A-6eqiC:
24.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f3d INTERLEUKIN-1
RECEPTOR-ASSOCIATED
KINASE 4

(Homo sapiens) 		no annotation 6 LEU A 215
LEU A 260
ASP A 311
LYS A 313
ASN A 316
GLY A 331
 None
 1.27A 4an2A-6f3dA:
20.2		 4an2A-6f3dA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1alq CP254 BETA-LACTAMASE

(Staphylococcus
aureus) 		PF13354
(Beta-lactamase2) 		4 ASN A 191
SER A 200
LEU A 199
THR A  51
 None
 1.47A 4an2A-1alqA:
0.0		 4an2A-1alqA:
22.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aun PR-5D

(Nicotiana
tabacum) 		PF00314
(Thaumatin) 		4 ASN A 106
SER A 137
LEU A 138
THR A  64
 None
 1.28A 4an2A-1aunA:
0.0		 4an2A-1aunA:
18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1axk GLUXYN-1

(Bacillus
subtilis) 		PF00457
(Glyco_hydro_11)
PF00722
(Glyco_hydro_16) 		4 ASN A 208
SER A 240
LEU A 222
THR A 206
 None
 1.42A 4an2A-1axkA:
undetectable		 4an2A-1axkA:
19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dkp PHYTASE

(Escherichia
coli) 		PF00328
(His_Phos_2) 		4 ASN A 251
SER A 206
LEU A 207
THR A 327
 None
None
None
HG  A 503 ( 3.7A)
 1.41A 4an2A-1dkpA:
0.3		 4an2A-1dkpA:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fep FERRIC ENTEROBACTIN
RECEPTOR

(Escherichia
coli) 		PF00593
(TonB_dep_Rec)
PF07715
(Plug) 		4 ASN A 534
SER A 590
LEU A 599
THR A 506
 None
 1.48A 4an2A-1fepA:
0.1		 4an2A-1fepA:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fpq ISOLIQUIRITIGENIN
2'-O-METHYLTRANSFERA
SE

(Medicago sativa) 		PF00891
(Methyltransf_2)
PF08100
(Dimerisation) 		4 ASN A  42
SER A  94
LEU A  91
THR A 136
 None
 1.32A 4an2A-1fpqA:
0.7		 4an2A-1fpqA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fs2 SKP2

(Homo sapiens) 		PF12937
(F-box-like) 		4 ASN A 236
SER A 224
LEU A 225
THR A 262
 None
 1.36A 4an2A-1fs2A:
undetectable		 4an2A-1fs2A:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hwn EBULIN

(Sambucus ebulus) 		PF00161
(RIP) 		4 ASN A  61
SER A 177
LEU A 178
THR A 142
 None
 1.46A 4an2A-1hwnA:
undetectable		 4an2A-1hwnA:
21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ikp EXOTOXIN A

(Pseudomonas
aeruginosa) 		PF09009
(Exotox-A_cataly)
PF09101
(Exotox-A_bind)
PF09102
(Exotox-A_target) 		4 ASN A 112
SER A  65
LEU A  64
THR A 273
 None
NA  A 703 ( 4.5A)
None
None
 1.33A 4an2A-1ikpA:
0.4		 4an2A-1ikpA:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kqf FORMATE
DEHYDROGENASE,
NITRATE-INDUCIBLE,
MAJOR SUBUNIT

(Escherichia
coli) 		PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
PF04879
(Molybdop_Fe4S4) 		4 ASN A 144
SER A 461
LEU A 187
THR A 550
 None
 1.31A 4an2A-1kqfA:
undetectable		 4an2A-1kqfA:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mox EPIDERMAL GROWTH
FACTOR RECEPTOR

(Homo sapiens) 		PF00757
(Furin-like)
PF01030
(Recep_L_domain) 		4 ASN A  40
SER A  99
LEU A  98
THR A  10
 None
 1.30A 4an2A-1moxA:
undetectable		 4an2A-1moxA:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p9m INTERLEUKIN-6
RECEPTOR BETA CHAIN

(Homo sapiens) 		PF00041
(fn3)
PF06328
(Lep_receptor_Ig)
PF09240
(IL6Ra-bind) 		4 ASN A 236
SER A 207
LEU A 206
THR A 255
 None
 1.20A 4an2A-1p9mA:
undetectable		 4an2A-1p9mA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r4n AMYLOID BETA
PRECURSOR
PROTEIN-BINDING
PROTEIN 1

(Homo sapiens) 		PF00899
(ThiF) 		4 ASN A  72
SER A 523
LEU A 158
THR A  39
 None
 1.48A 4an2A-1r4nA:
undetectable		 4an2A-1r4nA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1umr CONVULXIN BETA

(Crotalus
durissus) 		PF00059
(Lectin_C) 		4 ASN C 306
SER C 310
LEU C 309
THR C 247
 None
 1.45A 4an2A-1umrC:
undetectable		 4an2A-1umrC:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xp4 D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE

(Streptococcus
pneumoniae) 		PF00768
(Peptidase_S11)
PF07943
(PBP5_C) 		4 ASN A 163
SER A 122
LEU A  90
THR A 243
 None
 1.22A 4an2A-1xp4A:
undetectable		 4an2A-1xp4A:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yts YERSINIA PROTEIN
TYROSINE PHOSPHATASE

(Yersinia
enterocolitica) 		PF00102
(Y_phosphatase) 		4 ASN A 424
SER A 362
LEU A 457
THR A 254
 None
 1.49A 4an2A-1ytsA:
undetectable		 4an2A-1ytsA:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yz4 DUAL SPECIFICITY
PHOSPHATASE-LIKE 15
ISOFORM A

(Homo sapiens) 		PF00782
(DSPc) 		4 ASN A  83
SER A  95
LEU A  14
THR A  32
 None
SO4  A 211 ( 4.5A)
None
None
 1.39A 4an2A-1yz4A:
undetectable		 4an2A-1yz4A:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ass S-PHASE
KINASE-ASSOCIATED
PROTEIN 2

(Homo sapiens) 		PF12937
(F-box-like) 		4 ASN B2224
SER B2212
LEU B2213
THR B2250
 None
 1.28A 4an2A-2assB:
undetectable		 4an2A-2assB:
21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dpn GLYCEROL KINASE

(Thermus
thermophilus) 		PF00370
(FGGY_N)
PF02782
(FGGY_C) 		4 ASN A 271
SER A 279
LEU A 283
THR A 296
 None
 1.49A 4an2A-2dpnA:
undetectable		 4an2A-2dpnA:
20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e0i 432AA LONG
HYPOTHETICAL
DEOXYRIBODIPYRIMIDIN
E PHOTOLYASE

(Sulfurisphaera
tokodaii) 		PF00875
(DNA_photolyase)
PF03441
(FAD_binding_7) 		4 ASN A 145
SER A 133
LEU A 134
THR A 141
 None
 1.32A 4an2A-2e0iA:
undetectable		 4an2A-2e0iA:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eae ALPHA-FUCOSIDASE

(Bifidobacterium
bifidum) 		PF14498
(Glyco_hyd_65N_2) 		4 ASN A 695
SER A 730
LEU A 685
THR A 785
 None
 1.41A 4an2A-2eaeA:
undetectable		 4an2A-2eaeA:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eae ALPHA-FUCOSIDASE

(Bifidobacterium
bifidum) 		PF14498
(Glyco_hyd_65N_2) 		4 ASN A 755
SER A 162
LEU A 161
THR A  61
 None
 1.42A 4an2A-2eaeA:
undetectable		 4an2A-2eaeA:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gtr CHROMODOMAIN Y-LIKE
PROTEIN

(Homo sapiens) 		PF00378
(ECH_1) 		4 ASN A  31
SER A 118
LEU A 115
THR A  22
 None
 1.46A 4an2A-2gtrA:
undetectable		 4an2A-2gtrA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hga CONSERVED PROTEIN
MTH1368

(Methanothermobacter
thermautotrophicus) 		PF00595
(PDZ) 		4 ASN A  76
SER A  63
LEU A  66
THR A  78
 None
 1.41A 4an2A-2hgaA:
undetectable		 4an2A-2hgaA:
18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ivf ETHYLBENZENE
DEHYDROGENASE
ALPHA-SUBUNIT

(Aromatoleum
aromaticum) 		PF00384
(Molybdopterin)
PF01568
(Molydop_binding) 		4 ASN A 958
SER A 214
LEU A 543
THR A 224
 None
None
None
GOL  A1980 ( 4.9A)
 1.37A 4an2A-2ivfA:
undetectable		 4an2A-2ivfA:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j5g ALR4455 PROTEIN

(Nostoc sp. PCC
7120) 		PF00378
(ECH_1) 		4 ASN D  14
SER D 112
LEU D  64
THR D  31
 None
 1.15A 4an2A-2j5gD:
undetectable		 4an2A-2j5gD:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ka9 DISKS LARGE HOMOLOG
4

(Rattus
norvegicus) 		PF00595
(PDZ) 		4 ASN A 156
SER A 128
LEU A 153
THR A 175
 None
 1.32A 4an2A-2ka9A:
undetectable		 4an2A-2ka9A:
24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o0y TRANSCRIPTIONAL
REGULATOR

(Rhodococcus sp.) 		PF01614
(IclR)
PF09339
(HTH_IclR) 		4 ASN A 115
SER A 252
LEU A 212
THR A 113
 None
 1.47A 4an2A-2o0yA:
undetectable		 4an2A-2o0yA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wiu HTH-TYPE
TRANSCRIPTIONAL
REGULATOR HIPB

(Escherichia
coli) 		PF01381
(HTH_3) 		4 ASN B  15
SER B  63
LEU B  64
THR B  11
 None
 1.44A 4an2A-2wiuB:
undetectable		 4an2A-2wiuB:
15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wl7 DISKS LARGE HOMOLOG
2

(Mus musculus) 		PF00595
(PDZ) 		4 ASN A 149
SER A 161
LEU A 153
THR A 132
 CL  A1193 (-4.3A)
None
None
None
 1.25A 4an2A-2wl7A:
undetectable		 4an2A-2wl7A:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a1z HEMOLYMPH JUVENILE
HORMONE BINDING
PROTEIN

(Bombyx mori) 		PF06585
(JHBP) 		4 ASN A  66
SER A 162
LEU A 115
THR A  68
 None
 0.96A 4an2A-3a1zA:
undetectable		 4an2A-3a1zA:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3c0r UBIQUITIN
THIOESTERASE OTU1

(Saccharomyces
cerevisiae) 		PF02338
(OTU) 		4 ASN A 255
SER A 225
LEU A 226
THR A 259
 None
 1.25A 4an2A-3c0rA:
undetectable		 4an2A-3c0rA:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d3m EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4
GAMMA 2

(Homo sapiens) 		PF02020
(W2) 		4 ASN A 770
SER A 759
LEU A 762
THR A 774
 None
 1.14A 4an2A-3d3mA:
undetectable		 4an2A-3d3mA:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dwk PENICILLIN-BINDING
PROTEIN 2

(Staphylococcus
aureus) 		PF00905
(Transpeptidase)
PF00912
(Transgly) 		4 ASN A 418
SER A 454
LEU A 451
THR A 687
 None
SO4  A  26 (-3.1A)
None
None
 1.48A 4an2A-3dwkA:
undetectable		 4an2A-3dwkA:
18.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hs3 RIBOSE OPERON
REPRESSOR

(Lactobacillus
acidophilus) 		PF13377
(Peripla_BP_3) 		4 ASN A 235
SER A 182
LEU A 183
THR A 233
 None
 1.37A 4an2A-3hs3A:
undetectable		 4an2A-3hs3A:
24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hur ALANINE RACEMASE

(Oenococcus oeni) 		PF00842
(Ala_racemase_C)
PF01168
(Ala_racemase_N) 		4 ASN A 204
SER A  59
LEU A  22
THR A 207
 SO4  A 395 (-4.0A)
None
None
None
 1.38A 4an2A-3hurA:
undetectable		 4an2A-3hurA:
23.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ilv GLUTAMINE-DEPENDENT
NAD(+) SYNTHETASE

(Cytophaga
hutchinsonii) 		PF00795
(CN_hydrolase)
PF02540
(NAD_synthase) 		4 ASN A  12
SER A  82
LEU A  42
THR A  14
 None
 1.34A 4an2A-3ilvA:
undetectable		 4an2A-3ilvA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jcl SPIKE GLYCOPROTEIN

(Murine
coronavirus) 		PF01601
(Corona_S2)
PF09408
(Spike_rec_bind)
PF16451
(Spike_NTD) 		4 ASN A1048
SER A1026
LEU A1027
THR A1052
 None
 1.48A 4an2A-3jclA:
1.6		 4an2A-3jclA:
13.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l6a EUKARYOTIC
TRANSLATION
INITIATION FACTOR 4
GAMMA 2

(Homo sapiens) 		PF02020
(W2)
PF02847
(MA3) 		4 ASN A 233
SER A 222
LEU A 225
THR A 237
 None
 1.16A 4an2A-3l6aA:
undetectable		 4an2A-3l6aA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mkl HTH-TYPE
TRANSCRIPTIONAL
REGULATOR GADX

(Escherichia
coli) 		PF12833
(HTH_18) 		4 ASN A 142
SER A 171
LEU A 174
THR A 145
 None
 1.17A 4an2A-3mklA:
undetectable		 4an2A-3mklA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pnt IMMUNITY FACTOR FOR
SPN

(Streptococcus
pyogenes) 		PF16718
(IFS) 		4 ASN B  97
SER B 108
LEU B 109
THR B 160
 None
 1.33A 4an2A-3pntB:
undetectable		 4an2A-3pntB:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qk8 ENOYL-COA HYDRATASE
ECHA15

(Mycobacterium
marinum) 		PF00378
(ECH_1) 		4 ASN A  22
SER A  67
LEU A  25
THR A 199
 None
 1.30A 4an2A-3qk8A:
undetectable		 4an2A-3qk8A:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rks HYDROXYNITRILASE

(Manihot
esculenta) 		PF00561
(Abhydrolase_1) 		4 ASN A  52
SER A 115
LEU A 184
THR A 140
 None
 1.42A 4an2A-3rksA:
undetectable		 4an2A-3rksA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rpi LIGHT CHAIN FROM
HIGHLY POTENT
ANTI-HIV
NEUTRALIZING
ANTIBODY

(Homo sapiens) 		no annotation 4 ASN L 126
SER L 191
LEU L 190
THR L 161
 None
 1.43A 4an2A-3rpiL:
undetectable		 4an2A-3rpiL:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rpi LIGHT CHAIN FROM
HIGHLY POTENT
ANTI-HIV
NEUTRALIZING
ANTIBODY

(Homo sapiens) 		no annotation 4 ASN L 127
SER L 191
LEU L 190
THR L 161
 None
 1.49A 4an2A-3rpiL:
undetectable		 4an2A-3rpiL:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ss7 D-SERINE DEHYDRATASE

(Escherichia
coli) 		PF00291
(PALP) 		4 ASN X 170
SER X 241
LEU X 244
THR X 424
 PLP  X 502 (-3.8A)
None
None
PLP  X 502 (-3.0A)
 1.36A 4an2A-3ss7X:
undetectable		 4an2A-3ss7X:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sy8 ROCR

(Pseudomonas
aeruginosa) 		PF00072
(Response_reg)
PF00563
(EAL) 		4 ASN A 233
SER A 241
LEU A 244
THR A 267
 MG  A 401 (-2.7A)
None
None
None
 1.31A 4an2A-3sy8A:
undetectable		 4an2A-3sy8A:
24.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t8j PURINE NUCLEOSIDASE,
(IUNH-1)

(Sulfolobus
solfataricus) 		PF01156
(IU_nuc_hydro) 		4 ASN A 309
SER A  17
LEU A  20
THR A 208
 None
 1.49A 4an2A-3t8jA:
undetectable		 4an2A-3t8jA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tht ALKYLATED DNA REPAIR
PROTEIN ALKB HOMOLOG
8

(Homo sapiens) 		PF00076
(RRM_1)
PF13532
(2OG-FeII_Oxy_2) 		4 ASN A  49
SER A  93
LEU A  45
THR A 114
 None
 1.45A 4an2A-3thtA:
undetectable		 4an2A-3thtA:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tql ARGININE-BINDING
PROTEIN

(Coxiella
burnetii) 		PF00497
(SBP_bac_3) 		4 ASN A 109
SER A  91
LEU A  92
THR A 111
 ARG  A   1 (-3.6A)
None
None
None
 1.32A 4an2A-3tqlA:
undetectable		 4an2A-3tqlA:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3twi VARIABLE LYMPHOCYTE
RECEPTOR B

(Petromyzon
marinus) 		PF01462
(LRRNT)
PF13855
(LRR_8) 		4 ASN D  34
SER D  42
LEU D  40
THR D  32
 None
 1.41A 4an2A-3twiD:
undetectable		 4an2A-3twiD:
20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v98 ARACHIDONATE
5-LIPOXYGENASE

(Homo sapiens) 		PF00305
(Lipoxygenase)
PF01477
(PLAT) 		4 ASN A 407
SER A 608
LEU A 607
THR A 403
 None
 1.37A 4an2A-3v98A:
undetectable		 4an2A-3v98A:
18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vzm ENDO-1,4-BETA-XYLANA
SE

(Bacillus
circulans) 		PF00457
(Glyco_hydro_11) 		4 ASN A  52
SER A  84
LEU A  66
THR A  50
 None
 1.40A 4an2A-3vzmA:
undetectable		 4an2A-3vzmA:
17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w0s HYGROMYCIN-B
4-O-KINASE

(Escherichia
coli) 		PF01636
(APH) 		4 ASN A 203
SER A  69
LEU A  72
THR A  99
 ANP  A 402 ( 4.6A)
None
None
None
 1.40A 4an2A-3w0sA:
6.6		 4an2A-3w0sA:
22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3znj 5-CHLOROMUCONOLACTON
E DEHALOGENASE

(Rhodococcus
opacus) 		PF02426
(MIase) 		4 ASN 1  10
SER 1  26
LEU 1  23
THR 1   8
 None
 1.31A 4an2A-3znj1:
undetectable		 4an2A-3znj1:
14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3znj 5-CHLOROMUCONOLACTON
E DEHALOGENASE

(Rhodococcus
opacus) 		PF02426
(MIase) 		4 ASN 1  10
SER 1  26
LEU 1  23
THR 1  78
 None
 1.48A 4an2A-3znj1:
undetectable		 4an2A-3znj1:
14.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4anj UNCONVENTIONAL
MYOSIN-VI, GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Sus scrofa) 		PF00063
(Myosin_head)
PF01353
(GFP) 		4 ASN A  76
SER A 687
LEU A 686
THR A  88
 None
 1.31A 4an2A-4anjA:
1.4		 4an2A-4anjA:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4arv PHYTASE

(Yersinia
kristensenii) 		PF00328
(His_Phos_2) 		4 ASN A 171
SER A 247
LEU A 165
THR A  34
 None
 1.19A 4an2A-4arvA:
undetectable		 4an2A-4arvA:
22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4buj ANTIVIRAL PROTEIN
SKI8

(Saccharomyces
cerevisiae) 		PF00400
(WD40) 		4 ASN C 222
SER C 195
LEU C 199
THR C 208
 None
 1.30A 4an2A-4bujC:
undetectable		 4an2A-4bujC:
22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c23 L-FUCULOSE KINASE
FUCK

(Streptococcus
pneumoniae) 		PF00370
(FGGY_N)
PF02782
(FGGY_C) 		4 ASN A 124
SER A 110
LEU A 115
THR A 177
 None
 1.43A 4an2A-4c23A:
undetectable		 4an2A-4c23A:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cvu BETA-MANNOSIDASE

(Trichoderma
harzianum) 		PF00703
(Glyco_hydro_2) 		4 ASN A 855
SER A 884
LEU A 885
THR A 658
 None
 1.49A 4an2A-4cvuA:
undetectable		 4an2A-4cvuA:
16.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dgu PUTATIVE CELL
ADHESION PROTEIN

(Bacteroides
thetaiotaomicron) 		no annotation 4 ASN A 208
SER A 171
LEU A 172
THR A 206
 None
 1.47A 4an2A-4dguA:
undetectable		 4an2A-4dguA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e2a PUTATIVE
ACETYLTRANSFERASE

(Streptococcus
mutans) 		PF13673
(Acetyltransf_10) 		4 ASN A  78
SER A 126
LEU A 125
THR A  84
 None
 1.28A 4an2A-4e2aA:
undetectable		 4an2A-4e2aA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eb0 LCC

(uncultured
bacterium) 		PF12695
(Abhydrolase_5) 		4 ASN A 288
SER A 258
LEU A 274
THR A 230
 None
 1.43A 4an2A-4eb0A:
undetectable		 4an2A-4eb0A:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4eud SUCCINYL-COA:ACETATE
COENZYME A
TRANSFERASE

(Acetobacter
aceti) 		PF02550
(AcetylCoA_hydro)
PF13336
(AcetylCoA_hyd_C) 		4 ASN A 173
SER A 318
LEU A 319
THR A 137
 None
 1.48A 4an2A-4eudA:
undetectable		 4an2A-4eudA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fgv CHROMOSOME REGION
MAINTENANCE 1 (CRM1)
OR EXPORTIN 1 (XPO1)

(Chaetomium
thermophilum) 		PF03810
(IBN_N)
PF08389
(Xpo1)
PF08767
(CRM1_C) 		4 ASN A 194
SER A 200
LEU A 201
THR A 229
 None
 1.14A 4an2A-4fgvA:
undetectable		 4an2A-4fgvA:
15.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gbf PHIKZ131

(Pseudomonas
virus phiKZ) 		no annotation 4 ASN A 575
SER A 505
LEU A 516
THR A 587
 None
 1.39A 4an2A-4gbfA:
undetectable		 4an2A-4gbfA:
22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gnr ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN-BRANCHED
CHAIN AMINO ACID
TRANSPORT

(Streptococcus
pneumoniae) 		PF13458
(Peripla_BP_6) 		4 ASN A 265
SER A  91
LEU A  53
THR A 314
 None
 1.38A 4an2A-4gnrA:
undetectable		 4an2A-4gnrA:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hum PROTEIN B

(Escherichia
coli) 		PF00041
(fn3) 		4 ASN B  88
SER B  17
LEU B  18
THR B  39
 None
 1.45A 4an2A-4humB:
undetectable		 4an2A-4humB:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jhp X-LINKED RETINITIS
PIGMENTOSA GTPASE
REGULATOR

(Homo sapiens) 		PF00415
(RCC1) 		4 ASN C 107
SER C 152
LEU C 100
THR C 137
 None
 1.47A 4an2A-4jhpC:
undetectable		 4an2A-4jhpC:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k15 LMO2686 PROTEIN

(Listeria
monocytogenes) 		no annotation 4 ASN A 160
SER A 127
LEU A 130
THR A 162
 None
 1.49A 4an2A-4k15A:
undetectable		 4an2A-4k15A:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mu6 KINECTIN 1 (KINESIN
RECEPTOR)

(Legionella
pneumophila) 		no annotation 4 ASN A 106
SER A 175
LEU A 176
THR A 102
 None
 1.25A 4an2A-4mu6A:
undetectable		 4an2A-4mu6A:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p1n ATG1 TMIT

(Kluyveromyces
marxianus) 		PF12063
(DUF3543) 		4 ASN A 570
SER A 679
LEU A 683
THR A 697
 None
 1.20A 4an2A-4p1nA:
undetectable		 4an2A-4p1nA:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qex ANTIBODY HEAVY CHAIN

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 ASN H 195
SER H 160
LEU H 158
THR H 150
 None
 1.35A 4an2A-4qexH:
undetectable		 4an2A-4qexH:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uf7 GLYCOPROTEIN

(Ghanaian bat
henipavirus) 		PF00423
(HN) 		4 ASN A 224
SER A 288
LEU A 265
THR A 226
 None
 1.44A 4an2A-4uf7A:
0.9		 4an2A-4uf7A:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4whb PHENYLUREA HYDROLASE
B

(Mycolicibacterium
brisbanense) 		no annotation 4 ASN E 331
SER E 254
LEU E 260
THR E 327
 None
 1.40A 4an2A-4whbE:
undetectable		 4an2A-4whbE:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yfz OUTER CAPSID PROTEIN
VP4

(Rotavirus A) 		no annotation 4 ASN A 176
SER A  74
LEU A  76
THR A 105
 None
 1.39A 4an2A-4yfzA:
undetectable		 4an2A-4yfzA:
22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zhj MG-CHELATASE SUBUNIT
CHLH

(Synechocystis
sp. PCC 6803) 		PF02514
(CobN-Mg_chel)
PF11965
(DUF3479) 		4 ASN A1161
SER A1212
LEU A1211
THR A1201
 None
 1.39A 4an2A-4zhjA:
undetectable		 4an2A-4zhjA:
13.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zo6 LIN1840 PROTEIN

(Listeria
innocua) 		PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like) 		4 ASN A 253
SER A 321
LEU A 324
THR A 247
 None
 1.36A 4an2A-4zo6A:
undetectable		 4an2A-4zo6A:
18.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a8q PUTATIVE RETAINING
B-GLYCOSIDASE

(Saccharophagus
degradans) 		PF00150
(Cellulase) 		4 ASN A  72
SER A  88
LEU A  89
THR A 328
 None
 1.06A 4an2A-5a8qA:
undetectable		 4an2A-5a8qA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aa4 MEMBRANE-BOUND LYTIC
MUREIN
TRANSGLYCOSYLASE F

(Pseudomonas
aeruginosa) 		PF00497
(SBP_bac_3)
PF01464
(SLT) 		4 ASN B  51
SER B 159
LEU B 156
THR B  86
 None
 1.15A 4an2A-5aa4B:
undetectable		 4an2A-5aa4B:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5b37 TRYPTOPHAN
DEHYDROGENASE

(Nostoc
punctiforme) 		PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N) 		4 ASN A 309
SER A 147
LEU A 148
THR A 313
 None
 1.48A 4an2A-5b37A:
undetectable		 4an2A-5b37A:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c3l NUCLEOPORIN NUP58
NUP54

(Xenopus laevis) 		PF13874
(Nup54)
PF15967
(Nucleoporin_FG2) 		4 ASN A 392
SER B 329
LEU B 328
THR A 396
 None
 1.36A 4an2A-5c3lA:
undetectable		 4an2A-5c3lA:
23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dv0 SORTASE SRTA

(Streptococcus
pneumoniae) 		PF04203
(Sortase) 		4 ASN A 117
SER A 155
LEU A 153
THR A 124
 None
 1.46A 4an2A-5dv0A:
undetectable		 4an2A-5dv0A:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5evm FUSION GLYCOPROTEIN
F0

(Nipah
henipavirus) 		PF00523
(Fusion_gly) 		4 ASN A  84
SER A 208
LEU A 207
THR A  88
 None
 1.14A 4an2A-5evmA:
undetectable		 4an2A-5evmA:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ewp ARO (ARMADILLO
REPEATS ONLY
PROTEIN)

(Plasmodium
falciparum) 		no annotation 4 ASN A 200
SER A 266
LEU A 254
THR A 196
 None
 1.28A 4an2A-5ewpA:
undetectable		 4an2A-5ewpA:
22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fl7 ATP SYNTHASE SUBUNIT
BETA

(Yarrowia
lipolytica) 		PF00006
(ATP-synt_ab)
PF02874
(ATP-synt_ab_N) 		4 ASN D 404
SER D 386
LEU D 389
THR D 408
 None
 1.36A 4an2A-5fl7D:
undetectable		 4an2A-5fl7D:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i51 TRANSKETOLASE

(Scheffersomyces
stipitis) 		PF00456
(Transketolase_N)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C) 		4 ASN A 441
SER A 377
LEU A 380
THR A 483
 None
 1.24A 4an2A-5i51A:
undetectable		 4an2A-5i51A:
18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5imt INTERMEDILYSIN

(Streptococcus
intermedius) 		PF01289
(Thiol_cytolysin)
PF17440
(Thiol_cytolys_C) 		4 ASN A 287
SER A 269
LEU A  64
THR A 290
 None
 1.34A 4an2A-5imtA:
undetectable		 4an2A-5imtA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5imw INTERMEDILYSIN

(Streptococcus
intermedius) 		PF01289
(Thiol_cytolysin)
PF17440
(Thiol_cytolys_C) 		4 ASN A 287
SER A 269
LEU A  64
THR A 290
 None
 1.44A 4an2A-5imwA:
undetectable		 4an2A-5imwA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5utk ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF00041
(fn3) 		4 ASN A 560
SER A 666
LEU A 634
THR A 562
 None
 1.43A 4an2A-5utkA:
undetectable		 4an2A-5utkA:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wdu ENVELOPE
GLYCOPROTEIN GP160

(Human
immunodeficiency
virus 1) 		no annotation 4 ASN G 295
SER G 256
LEU G 261
THR G 297
 NAG  G 634 (-1.9A)
None
NAG  G 627 ( 4.8A)
NAG  G 641 (-3.4A)
 1.44A 4an2A-5wduG:
undetectable		 4an2A-5wduG:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wq8 TYPE II SECRETION
SYSTEM PROTEIN D

(Vibrio cholerae) 		PF00263
(Secretin)
PF03958
(Secretin_N) 		4 ASN A 354
SER A 413
LEU A 422
THR A 568
 None
 1.31A 4an2A-5wq8A:
2.9		 4an2A-5wq8A:
19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xog RNA POLYMERASE II
SUBUNIT B12.5
RNA POLYMERASE II
THIRD LARGEST
SUBUNIT B44, PART OF
CENTRAL CORE

(Komagataella
phaffii) 		PF01000
(RNA_pol_A_bac)
PF01193
(RNA_pol_L)
PF13656
(RNA_pol_L_2) 		4 ASN K  96
SER C  31
LEU K  45
THR K 100
 None
 1.20A 4an2A-5xogK:
3.1		 4an2A-5xogK:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ar3 GSI-IIC RT

(Geobacillus
stearothermophilus) 		no annotation 4 ASN A  12
SER A 196
LEU A 195
THR A  15
 None
 1.35A 4an2A-6ar3A:
1.9		 4an2A-6ar3A:
23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bzg SPORULATION-SPECIFIC
PROTEIN 16

(Saccharomyces
cerevisiae) 		no annotation 4 ASN A  83
SER A 101
LEU A  98
THR A  85
 None
 1.47A 4an2A-6bzgA:
undetectable		 4an2A-6bzgA:
17.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c01 ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 3

(Homo sapiens) 		no annotation 4 ASN A 594
SER A 632
LEU A 625
THR A 596
 NAG  A 925 (-1.9A)
None
None
NAG  A 925 (-4.2A)
 1.11A 4an2A-6c01A:
undetectable		 4an2A-6c01A:
13.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cfw MBH SUBUNIT
MONOVALENT CATION/H+
ANTIPORTER SUBUNIT B

(Pyrococcus
furiosus) 		no annotation 4 ASN F 122
SER F 107
LEU F 113
THR E  61
 None
 1.49A 4an2A-6cfwF:
undetectable		 4an2A-6cfwF:
18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cfz DAD1,DAD1
DUO1

(Chaetomium
thermophilum) 		no annotation 4 ASN D  82
SER F  48
LEU F  49
THR D  85
 None
 1.49A 4an2A-6cfzD:
undetectable		 4an2A-6cfzD:
16.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cty DIHYDROOROTASE

(Yersinia pestis) 		no annotation 4 ASN A  45
SER A  27
LEU A  26
THR A 111
 MLT  A 403 (-3.6A)
None
None
MLT  A 403 (-3.2A)
 1.40A 4an2A-6ctyA:
undetectable		 4an2A-6ctyA:
13.99